Last reviewed · How we verify
NCT05006950
SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.
Phase 1 trial testing Stryker1688 Fluorescence imaging system in Cholecystitis in 50 participants. Terminated before completion.
8 February 2022
Quick facts
| Lead sponsor | Stryker Endoscopy |
|---|---|
| Phase | Phase 1 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 50 |
| Start date | 28 June 2021 |
| Primary completion | 8 February 2022 |
| Estimated completion | 7 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stryker1688 Fluorescence imaging system
Conditions studied
- Cholecystitis — all drugs for Cholecystitis →
Sponsor
Stryker Endoscopy
Who can join
18 and older, any sex, with Cholecystitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective single arm, single center study estimating percentage of successful critical anatomy recognition in laparoscopic cholecystectomy surgeries using SPY fluorescence imaging and ICG, with each surgery also providing a white light 360 degree images. The primary objective is to determine the percentage of successful critical anatomy recognition using intra-operative SPY fluorescence imaging and ICG: and to describe complications associated with intra-operative decision making in patients undergoing laparoscopic cholecystectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05006950
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cholecystitis
Currently open trials in the same condition.
- NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
- NCT07222527 — One vs. Two Stents for Gallbladder Disease · NA · recruiting
- NCT06656299 — EOIB for Laparoscopic Cholecystectomy · NA · recruiting
- NCT06740903 — Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy · Phase 2, PHASE3 · recruiting
- NCT06502028 — Video Laryngeal Mask Versus Endotracheal Tube Undergoing Laparoscopic Cholecystectomy Surgery · NA · recruiting
Other Stryker Endoscopy trials
Trials by the same sponsor.
- NCT06320925 — SportsPro: Post-Market Clinical Follow Up Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006950 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stryker Endoscopy
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006950.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing